Webcasts

Wednesday October 27th, 2021 at 10am EDT | 7am PDT | 3pm BST | 4pm CEST
Antibody products have evolved to be the cornerstone of the biopharmaceutical market and are a driving force in the pharmaceutical landscape. A variety of tools and technologies have contributed to the success and unrivaled growth of antibody products, learn how current and novel technologies may impact antibody product growth in the coming decades. 

Antibody Products in the Marketplace – Past, Present and Future Growth Drivers

Tuesday, October 26, 2021 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
Are you planning to turn your analytical HPLC method into a purification method? Are you converting your analytical-scale purification method to semi-prep or production scale? Learn how to set appropriate purification goals for purity, yield and throughput and what type of equipment will best fit your application.

Analytical-Scale Prep, Semi-Prep, Process Scale Preparative Chromatography: To Infinity and Beyond!

Thursday, October 21, 2021 at 4pm CEST |10am EDT| 7am PDT| 3pm BST
Protect not only your valuable product but also public health by ensuring correct storage choices.  Gain insight into the effects of deep cold storage and a holistic approach to ensure Container Closure Integrity of sterile pharmaceuticals. 

Container Closure Integrity of Product Requiring Deep Cold Storage

Tuesday, October 19, 2021 at 10am EDT| 7am PDT| 3pm BST| 4pm CEST
Join this webcast on digital tools for guiding the formulation development of poorly soluble drugs to learn about recent features of BASF’s virtual formulation assistant. Explore how to identify the most suitable formulation approach for your active ingredient.

 Structured Formulation Development of Poorly Soluble Drugs Guided by a Virtual Formulation Assistant

October 4, 2021 at 3pm BST | 10am EST | 4pm CEST
Join global industry and regulatory experts as they discuss current hot topics in extractables and leachables (E&L) testing for pharmaceuticals, biopharmaceuticals and medical devices.

The Ever-Changing World of Extractables and Leachables: Lessons learned and future challenges

Thursday, September 30, 2021 at 11am EDT| 8am PDT| 4pm BST| 5pm CEST
In-vitro biochemical assays make the high-throughput screening of large compound libraries possible; however,  without a strong hit-to-lead process, time and money are often wasted seeking out the most promising starting points. Register for this webinar to learn best practices for triaging hits and focusing efforts.

Hit-to-Lead Optimization Strategy In Drug Discovery 

Thursday, September 30, 2021 at 1pm EDT| 12pm CDT| 10am PDT
Formulating drugs to facilitate patient adherence, especially for pediatrics, is an ongoing industry challenge. Learn about challenges encountered when formulating drugs with a patient-centric focus, clinical recommendations for pediatric dosage forms, repurposing strategies for formulation development, and technology platforms to optimize oral dosage forms. 

Strategies for Effective Patient-Centric Dosage Formulations

Tuesday, September 28, 2021 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST

In the last few years, the issuance of the ISO 10993-18:2020 medical device guidance and several high-profile publications and round-robin studies have resulted in the FDA increasing scrutiny of E&L analyses for both drugs and devices. Join our panel of industry experts to discuss these changes and to learn the direction E&L may take into the future. 

Extractables and Leachables: Trends and Future Directions A roundtable discussion

Thursday, September 16, 2021 at 10am EDT| 7am PDT| 3pm BST| 4pm CEST

Choosing the right sterilization technique for your drug product and its packaging is not always a simple decision. Join the webcast on September 15th to learn about standard sterilization processes, be introduced to newer techniques, and understand how these techniques have been applied to parenteral packaging components.

Sterilization Techniques for Parenteral Packaging

Wednesday, September 15, 2021 at 10am EDTDrug manufacturing demands and increased regulatory oversight are prompting pharmaceutical manufacturers to consider new processes for oral solid dose and aseptically processed drugs. A cross-section of industry experts will offer insight on emerging trends, technologies, and processes in this Technology Forum. 